Cargando…

Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic

BACKGROUND: Seven-day clinical pharmacy services in the acute sector of the National Health Service are limited. There is a paucity of evidential patient benefit. This limits investment and infrastructure, despite United Kingdom wide calls. AIM: To optimise medicines seven-days a week during surge-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, C., Walsh, A., Jones, S., Matthews, S., Weerasooriya, D., Fernandes, R. J., McKenzie, C. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650667/
https://www.ncbi.nlm.nih.gov/pubmed/36367601
http://dx.doi.org/10.1007/s11096-022-01475-8
_version_ 1784828072902524928
author Cheng, C.
Walsh, A.
Jones, S.
Matthews, S.
Weerasooriya, D.
Fernandes, R. J.
McKenzie, C. A.
author_facet Cheng, C.
Walsh, A.
Jones, S.
Matthews, S.
Weerasooriya, D.
Fernandes, R. J.
McKenzie, C. A.
author_sort Cheng, C.
collection PubMed
description BACKGROUND: Seven-day clinical pharmacy services in the acute sector of the National Health Service are limited. There is a paucity of evidential patient benefit. This limits investment and infrastructure, despite United Kingdom wide calls. AIM: To optimise medicines seven-days a week during surge-2 of the COVID-19 pandemic through implementation of a seven-day clinical pharmacy service. This paper describes service development, evaluation and sustainability. SETTING: A tertiary-referral teaching hospital, London, United Kingdom. DEVELOPMENT: The seven-day clinical pharmacy service was developed to critical care, acute and general medical patients. Clinical leads developed the service specification and defined priorities, targeting complex patients and transfer of care. Contributing staff were briefed and training materials developed. IMPLEMENTATION: The service was implemented in January 2021 for 11 weeks. Multidisciplinary team communication brought challenges; strategies were employed to overcome these. EVALUATION: A prospective observational study was conducted in intervention wards over two weekends in February 2021. 1584 beds were occupied and 602 patients included. 346 interventions were reported and rated; 85.6% had high or moderate impact; 56.7% were time-critical. The proportion of medicines reconciliation within 24-h of admission was analysed across the hospital between November 2020 and May 2021. During implementation, patients admitted Friday-Sunday were more likely to receive medicines reconciliation within 24-h (RR 1.41 (95% CI 1.34–1.47), p < 0.001). Rostered services were delivered sustainably in terms of shift-fill rate and medicines reconciliation outcome. CONCLUSION: Seven-day clinical pharmacy services benefit patient outcome through early medicines reconciliation and intervention. Investment to permanently embed the service was sustained.
format Online
Article
Text
id pubmed-9650667
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-96506672022-11-14 Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic Cheng, C. Walsh, A. Jones, S. Matthews, S. Weerasooriya, D. Fernandes, R. J. McKenzie, C. A. Int J Clin Pharm ESCP Best Practice BACKGROUND: Seven-day clinical pharmacy services in the acute sector of the National Health Service are limited. There is a paucity of evidential patient benefit. This limits investment and infrastructure, despite United Kingdom wide calls. AIM: To optimise medicines seven-days a week during surge-2 of the COVID-19 pandemic through implementation of a seven-day clinical pharmacy service. This paper describes service development, evaluation and sustainability. SETTING: A tertiary-referral teaching hospital, London, United Kingdom. DEVELOPMENT: The seven-day clinical pharmacy service was developed to critical care, acute and general medical patients. Clinical leads developed the service specification and defined priorities, targeting complex patients and transfer of care. Contributing staff were briefed and training materials developed. IMPLEMENTATION: The service was implemented in January 2021 for 11 weeks. Multidisciplinary team communication brought challenges; strategies were employed to overcome these. EVALUATION: A prospective observational study was conducted in intervention wards over two weekends in February 2021. 1584 beds were occupied and 602 patients included. 346 interventions were reported and rated; 85.6% had high or moderate impact; 56.7% were time-critical. The proportion of medicines reconciliation within 24-h of admission was analysed across the hospital between November 2020 and May 2021. During implementation, patients admitted Friday-Sunday were more likely to receive medicines reconciliation within 24-h (RR 1.41 (95% CI 1.34–1.47), p < 0.001). Rostered services were delivered sustainably in terms of shift-fill rate and medicines reconciliation outcome. CONCLUSION: Seven-day clinical pharmacy services benefit patient outcome through early medicines reconciliation and intervention. Investment to permanently embed the service was sustained. Springer International Publishing 2022-11-11 2023 /pmc/articles/PMC9650667/ /pubmed/36367601 http://dx.doi.org/10.1007/s11096-022-01475-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle ESCP Best Practice
Cheng, C.
Walsh, A.
Jones, S.
Matthews, S.
Weerasooriya, D.
Fernandes, R. J.
McKenzie, C. A.
Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic
title Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic
title_full Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic
title_fullStr Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic
title_full_unstemmed Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic
title_short Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic
title_sort development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the covid-19 pandemic
topic ESCP Best Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650667/
https://www.ncbi.nlm.nih.gov/pubmed/36367601
http://dx.doi.org/10.1007/s11096-022-01475-8
work_keys_str_mv AT chengc developmentimplementationandevaluationofasevendayclinicalpharmacyserviceinatertiaryreferralteachinghospitalduringsurge2ofthecovid19pandemic
AT walsha developmentimplementationandevaluationofasevendayclinicalpharmacyserviceinatertiaryreferralteachinghospitalduringsurge2ofthecovid19pandemic
AT joness developmentimplementationandevaluationofasevendayclinicalpharmacyserviceinatertiaryreferralteachinghospitalduringsurge2ofthecovid19pandemic
AT matthewss developmentimplementationandevaluationofasevendayclinicalpharmacyserviceinatertiaryreferralteachinghospitalduringsurge2ofthecovid19pandemic
AT weerasooriyad developmentimplementationandevaluationofasevendayclinicalpharmacyserviceinatertiaryreferralteachinghospitalduringsurge2ofthecovid19pandemic
AT fernandesrj developmentimplementationandevaluationofasevendayclinicalpharmacyserviceinatertiaryreferralteachinghospitalduringsurge2ofthecovid19pandemic
AT mckenzieca developmentimplementationandevaluationofasevendayclinicalpharmacyserviceinatertiaryreferralteachinghospitalduringsurge2ofthecovid19pandemic